Yishen Huatan Huoxue decoction and quercetin ameliorate decidualization dysfunction in polycystic ovary syndrome: A comprehensive investigation combining clinical trial and experimental studies
Drug Discoveries & Therapeutics · 2024
DOI: 10.5582/ddt.2024.01003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Discoveries & Therapeutics, 2024. Verfasst von Jing Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Reproductive Immunology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Quercetin, Drugs, Chinese Herbal. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 52 Literaturangaben.
Abstract (Originalsprache)
Polycystic ovary syndrome (PCOS) is a common gynecological endocrine disorder characterized by a complex pathogenesis and limited treatment options. Yishen Huatan and Huoxue decoction (YHHD), as a traditional Chinese Medicine formula, has shown effectiveness in treating PCOS. However, the specific mechanisms by which YHHD exerts its therapeutic effects remain unclear. In this study, we performed to investigate the therapeutic effects of YHHD and quercetin on dehydroepiandrosterone-induced PCOS mice, and examine the effect of quercetin on the decidualization of T-HESCs under hyperinsulinemic conditions. The results showed that YHHD could reduce early miscarriage rates in PCOS patients and significantly improved glucose metabolism disorders, sex hormone levels, and the estrous cycles in PCOS mice. Quercetin could alleviate effect of high insulin levels and restore the low expression of insulin receptor substrate1/2 (IRS1/2) and glucose transporte 4 (GLUT4) in T-HESCs, demonstrating its potential to mitigate hyperinsulin-induced decidualization dysfunction via the GLUT4 signaling pathway mediated by IRS1/2. This study provides valuable molecular insights of YHHD and highlight the therapeutic potential of quercetin in treating decidualization dysfunction in PCOS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory for Reproductive Immunology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China.
- The Academy of Integrative Medicine of Fudan University, Shanghai, China.
- Shanghai Key Laboratory of Female Reproductive Endocrine-related Diseases, Shanghai, China.
Zitieren
APA
Wang, J., Li, L., Zhou, J., Pan, X., Qi, Q., Sun, H., & Wang, L. (2024). Yishen Huatan Huoxue decoction and quercetin ameliorate decidualization dysfunction in polycystic ovary syndrome: A comprehensive investigation combining clinical trial and experimental studies. Drug Discoveries & Therapeutics. https://doi.org/10.5582/ddt.2024.01003
Vancouver
Wang J, Li L, Zhou J, Pan X, Qi Q, Sun H, et al. Yishen Huatan Huoxue decoction and quercetin ameliorate decidualization dysfunction in polycystic ovary syndrome: A comprehensive investigation combining clinical trial and experimental studies. Drug Discoveries & Therapeutics. 2024. doi:10.5582/ddt.2024.01003
BibTeX
@article{Wang2024,
author = {Wang, Jing and Li, Lisha and Zhou, Jing and Pan, Xinyao and Qi, Qing and Sun, Hongmei and Wang, Ling},
title = {Yishen Huatan Huoxue decoction and quercetin ameliorate decidualization dysfunction in polycystic ovary syndrome: A comprehensive investigation combining clinical trial and experimental studies},
journal = {Drug Discoveries & Therapeutics},
year = {2024},
doi = {10.5582/ddt.2024.01003}
}
EUVIMED